| Author (Person) | Mansnérus, Juli |
|---|---|
| Series Title | European Journal of Health Law |
| Series Details | Vol.22, No.3, June 2015, p267 – 286 |
| Publication Date | June 2015 |
| ISSN | 0929-0273 |
| Content Type | Journal | Series | Blog |
|
Abstract: The European Court of Justice (ecj) has recently issued a ruling in Case C-364/13 International Stem Cell Corporation v. Comptroller General of Patents Designs and Trademarks (Case) that aims at harmonising the patenting practices regarding interpretation of Article 6.2.c of Directive 98/44/ec (Biotech Patent Directive) in respect of patentability of human parthenogenic stem cells (hpSCs). The Case alters the patenting regime for human embryonic stem cell (hESC) applications, by stating that moral restrictions against hESC-patents are only applicable to such cells derived from embryos that had the potential to develop into a human being. Consequently, hpSC-based inventions may be patentable in Europe. This Case represents a leap forward to striking a balance between protecting human dignity and integrity whilst granting patent incentives for biomedical research. |
|
| Source Link | Link to Main Source http://dx.doi.org/10.1163/15718093-12341356 |
| Subject Categories | Health |
| Countries / Regions | Europe |
